People

Found 56,873 articles

• Cornerstone Pharmaceuticals Strengthens Scientific Advisory Board with the Appointment of Distinguished Scholar Jason Locasale, Ph.D.

  7/6/2022

  Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”), a company focused on rare cancer therapeutics and formerly known as Rafael Pharmaceuticals, today announced the appointment of Jason Locasale, Ph.D., as a member of the Company’s Scientific Advisory Board.

• Femasys Inc. Announces Existing Board Member Charles Larsen as Chairperson of the Board

  7/6/2022

  Femasys Inc. today announced that Charles Larsen, a current member of Femasys’ Board of Directors, has been appointed to the role of non-executive Chair, replacing founder, president and chief executive officer, Kathy Lee-Sepsick.

• Trialjectory Appoints Gregory T. Simpson as Chief Marketing Officer

  7/6/2022

  Trialjectory  ("the Company"), the AI-powered decision-support platform for patients, healthcare providers, and pharmaceutical companies, announced today that it has appointed Gregory T. Simpson as the Company's Chief Marketing Officer, effective immediately.

• Cosette Pharmaceuticals Appoints Rick Casten as CFO Amid Transformational Growth

  7/6/2022

  Cosette Pharmaceuticals, Inc., a New Jersey-based specialty pharmaceutical company, today announced the appointment of Rick Casten as Chief Financial Officer (CFO), bolstering its executive leadership team.

• Asher Bio Appoints Independent Director Bob Deresiewicz, M.D., to its Board

  7/6/2022

  Asher Biotherapeutics , Inc. (Asher Bio), a biotechnology company developing precisely-targeted immunotherapies for cancer, chronic viral infections and autoimmune disorders, today announced the appointment of Bob Deresiewicz, M.D., to its Board of Directors.

• Kallyope, Pioneers in Drug Discovery via the Gut-Brain Axis, Advances Discovery and Development Teams With New Appointments

  7/6/2022

  Kallyope, Inc., a leading biotechnology company focused on identifying and developing therapeutics involving the gut-brain axis, today announced the promotion of Shirly Pinto , Ph.D., to Chief Scientific Officer and the appointments of Jiajun Liu, Ph.D., as Vice President and Head of Biometrics and Michael Crutchlow, M.D., as Vice President and Head of Translational Medicine.

• Dynatronics Announces Appointment of New Chief Information Officer; Krier to add Chief Financial Officer Responsibilities

  7/6/2022

  Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced changes to its management team.

• Harpoon Therapeutics Expands Leadership Team

  7/6/2022

  Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immunotherapy company developing novel T cell engagers, today announced the appointment of Wendy Chang to Senior Vice President, Human Resources and Banmeet Anand, Ph.D., to Senior Vice President, Translational Medicine.

• Marcel R. M. van den Brink, MD, PhD Appointed Chairman of Smart Immune’s Scientific Advisory Board

  7/6/2022

  Smart Immune SAS announced today that Dr. Marcel van den Brink has been appointed Chairman of its Scientific Advisory Board.

• Sharon O'Keefe Joins Apollo Endosurgery Board of Directors

  7/6/2022

  Apollo Endosurgery, Inc. announced that Sharon O'Keefe has joined the company's Board of Directors, effective July 6, 2022.

• Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Maria Törnsén

  7/6/2022

  Immunic, Inc., a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, announced the appointment of Maria Törnsén, an industry executive with 20 years of global commercial experience in U.S. and ex-U.S. markets, to its Board of Directors, effective July 5, 2022.

• Ambrx Biopharma Appoints Edward Hu and Kate Hermans to its Board of Directors

  7/5/2022

  Ambrx Biopharma Inc., or Ambrx, (NYSE: AMAM), a clinical stage biopharmaceutical company using an expanded genetic code technology platform to create Engineered Precision Biologics (EPBs), today announced the appointments of Edward Hu and Kate Hermans to its Board of Directors.

• LabConnect, Inc. Announces Expansion of its Operations in Europe with Acquisition of Cryo Store B.V. and the Appointment of Marc van Kempen as General Manager Europe

  7/5/2022

  LabConnect Inc., a leading global provider of central laboratory and functional outsourcing services for biopharmaceutical, pharmaceutical, medical device, and contract research organizations, today announced that the company is expanding its operations into Europe with the appointment of Marc van Kempen as General Manager Europe.

• Aravive Appoints Dr. Robert B. Geller as Chief Medical Officer

  7/5/2022

  Aravive, Inc. (Nasdaq: ARAV, “the Company”), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today announced the appointment of Dr. Robert B. Geller as Chief Medical Officer.

• Eloxx Pharmaceuticals Announces Changes to Board of Directors

  7/5/2022

  Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today announced the appointment of Lindsay Androski, JD, MBA to its board of directors and as a member of the Board’s Audit Committee and Compensation Committee.

• ChemoCentryx Announces Appointment of Jennifer L. Herron to Board as Independent Director

  7/5/2022

  ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Jennifer L. Herron has been appointed to the Board as an independent director, effective June 28, 2022.

• DURECT Corporation Appoints Timothy M. Papp as Chief Financial Officer

  7/5/2022

  DURECT Corporation  (Nasdaq: DRRX), a biopharmaceutical company focused on epigenetic regulation to develop treatments for acute organ injury and chronic liver diseases, today announced the appointment of Timothy M. Papp as its Chief Financial Officer.

• Jaguar Health Appoints Senior Healthcare and Investment Executive Dr. Anula Jayasuriya to Board of Directors

  7/5/2022

  Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) today announced that it has appointed Anula Jayasuriya, M.D., Ph.D., M.B.A., to the company's Board of Directors, effective July 1, 2022.

• VESTECK, Inc. Continues to Expand Scientific Advisory Board

  7/5/2022

  VESTECK, Inc. Expands the Scientific Advisory Board to include an international luminary in complex aortic repair, Dr. Sukgu Han. 

• CANbridge Appoints Industry Leader Edward Hu to the Board

  7/5/2022

  Edward Hu to Replace Xiao Le as Non-Executive Director.